Ibex symposium at USCAP 2023 – The Beginning of a Beautiful Friendship

Back

We invited a “dream-team” of researchers to present new studies they have led at medical centers in the United States and Europe, showing the clinical utility and benefits of using Ibex AI for primary diagnosis. Our speakers were Stuart Schnitt, MD from Dana-Farber/Brigham and Women’s Cancer Center, Savitri Krishnamurthy, MD, from MD Anderson Cancer Center, Gregory Lauwers, MD from the Moffitt Cancer Center and Saira Shah, MD from Quest Diagnostics.

Back

About IBEX

IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.

By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.

About IBEX

IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.

By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.
Articles

How is artificial intelligence rising to the challenge in breast cancer diagnosis?

Articles

How ‘game-changing’ AI is helping discover cancer for the first time in UK | ITV News

Videos

The AI revolution in cancer diagnostics with Joseph Mossel, CEO of Ibex Medical Analytics